PEA

Silver X Mining Corp. released a Preliminary Economic Assessment (PEA) for its Nueva Recuperada project, targeting 6.2 million ounces of silver equivalent annually over a 14-year mine life. The PEA outlines a $439 million after-tax NPV (5% discount) and a 3-year payback, with an initial CapEx of $82 million. Production is planned across two mills at 3,000 tpd. The study relies on inferred resources, carrying inherent risks, and production decisions are not based on proven reserves or a feasibility study.

Prime Mining Corp. announced a successful shareholder meeting with all proposals approved and directors elected. The company, focused on its Los Reyes gold-silver project in Mexico, has a strong cash balance and is on track to deliver a Preliminary Economic Assessment in Q3 2025. Shareholder engagement was high, demonstrating confidence in Prime’s future.

SciSparc Ltd. announced a Japanese patent application for a novel pain management therapy. The application covers a combination of paracetamol and palmitoylethanolamide (PEA) designed to enhance pain and fever relief while potentially reducing side effects, including liver damage. This synergistic approach aims to improve treatment outcomes for various pain types and leverage the body’s endocannabinoid system.